• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

3q26.2/ 3号染色体臂间倒位所致重排:诊断挑战与临床病理特征

3q26.2/ Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features.

作者信息

Tang Zhenya, Wang Wei, Yang Su, El Achi Hanadi, Fang Hong, Nahmod Karen Amelia, Toruner Gokce A, Xu Jie, Thakral Beenu, Ayoub Edward, Issa Ghayas C, Yin C Cameron, You M James, Miranda Roberto N, Khoury Joseph D, Medeiros L Jeffrey, Tang Guilin

机构信息

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

Cancers (Basel). 2023 Jan 11;15(2):458. doi: 10.3390/cancers15020458.

DOI:10.3390/cancers15020458
PMID:36672407
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9856433/
Abstract

rearrangement () resulting from 3q26.2 aberrations is often associated with myeloid neoplasms and inferior prognosis in affected patients. Uncommonly, certain 3q26.2/ can be subtle/cryptic and consequently overlooked by karyotyping. We identified 17 acute myeloid leukemia (AML) patients (male/female: 13/4 with a median age of 67 years, range 42 to 85 years) with a pericentric inv(3) leading to with breakpoints at 3p23 (n = 11), 3p25 (n = 3), 3p21 (n = 2) and 3p13 (n = 1) on 3p and 3q26.2 on 3q. These pericentric inv(3)s were overlooked by karyotyping initially in 16 of 17 cases and later detected by metaphase FISH analysis. Similar to the patients with classic/paracentric inv(3)(q21q26.2), patients with pericentric inv(3) exhibited frequent cytopenia, morphological dysplasia (especially megakaryocytes), -7/del(7q), frequent (n = 6), (n = 5) and (n = 4) mutations and dismal outcomes (median overall survival: 14 months). However, patients with pericentric inv(3) more frequently had AML with thrombocytopenia (n = 15, 88%), relative monocytosis in peripheral blood (n = 15, 88%), decreased megakaryocytes (n = 11, 65%), and lower mutation. We conclude that AML with pericentric inv(3) shares some similarities with AML associated with classic/paracentric inv(3)/ but also shows certain unique features. Pericentric inv(3)s are often subtle/cryptic by chromosomal analysis. A reflex FISH analysis for is recommended in myeloid neoplasms showing -7/del(7q).

摘要

由3q26.2畸变导致的重排常与髓系肿瘤相关,且在受影响患者中预后较差。不常见的是,某些3q26.2异常可能很细微/隐匿,因此在核型分析中被忽视。我们识别出17例急性髓系白血病(AML)患者(男/女:13/4,中位年龄67岁,范围42至85岁),其发生了臂间倒位inv(3),导致3p上的断点位于3p23(n = 11)、3p25(n = 3)、3p21(n = 2)和3p13(n = 1),3q上的断点位于3q26.2。这些臂间倒位inv(3)最初在17例中的16例被核型分析遗漏,后来通过中期荧光原位杂交(FISH)分析检测到。与经典/臂内倒位inv(3)(q21q26.2)的患者相似,臂间倒位inv(3)的患者常出现血细胞减少、形态学发育异常(尤其是巨核细胞)、-7/del(7q)、频繁的 (n = 6)、 (n = 5)和 (n = 4)突变以及预后不良(中位总生存期:14个月)。然而,臂间倒位inv(3)的患者更常患有血小板减少的AML(n = 15,88%)、外周血相对单核细胞增多(n = 15,88%)、巨核细胞减少(n = 11,65%)以及较低的 突变。我们得出结论,伴有臂间倒位inv(3)的AML与伴有经典/臂内倒位inv(3)的AML有一些相似之处,但也表现出某些独特特征。臂间倒位inv(3)通过染色体分析通常很细微/隐匿。对于显示-7/del(7q)的髓系肿瘤,建议进行 相关的FISH分析。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/9856433/904ce1d040fe/cancers-15-00458-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/9856433/1e0fa8519308/cancers-15-00458-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/9856433/be1ed3f48e53/cancers-15-00458-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/9856433/82ba4342fae2/cancers-15-00458-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/9856433/904ce1d040fe/cancers-15-00458-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/9856433/1e0fa8519308/cancers-15-00458-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/9856433/be1ed3f48e53/cancers-15-00458-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/9856433/82ba4342fae2/cancers-15-00458-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8d06/9856433/904ce1d040fe/cancers-15-00458-g004.jpg

相似文献

1
3q26.2/ Rearrangements by Pericentric Inv(3): Diagnostic Challenges and Clinicopathologic Features.3q26.2/ 3号染色体臂间倒位所致重排:诊断挑战与临床病理特征
Cancers (Basel). 2023 Jan 11;15(2):458. doi: 10.3390/cancers15020458.
2
Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia.急性髓系白血病中存在非典型 3q26/MECOM 重排导致的 inv(3)/t(3;3)。
Blood. 2020 Jul 9;136(2):224-234. doi: 10.1182/blood.2019003701.
3
Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activation.具有非经典3q26.2/MECOM与经典inv(3)/t(3;3)重排的髓系肿瘤的比较揭示了MECOM激活的不同临床病理特征、基因谱和分子机制。
Genes Chromosomes Cancer. 2022 Feb;61(2):71-80. doi: 10.1002/gcc.23004. Epub 2021 Oct 28.
4
Complex chromosomal rearrangements leading to MECOM overexpression are recurrent in myeloid malignancies with various 3q abnormalities.导致MECOM过表达的复杂染色体重排在伴有各种3q异常的髓系恶性肿瘤中反复出现。
Genes Chromosomes Cancer. 2016 Apr;55(4):375-88. doi: 10.1002/gcc.22341. Epub 2016 Jan 27.
5
Deciphering the complexities of MECOM rearrangement-driven chromosomal aberrations.解读MECOM重排驱动的染色体畸变的复杂性。
Cancer Genet. 2019 Apr;233-234:21-31. doi: 10.1016/j.cancergen.2019.03.002. Epub 2019 Mar 11.
6
Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.在 27 例急性髓系白血病病例中发现了三种新型细胞遗传学隐匿性 EVI1 重排,这些重排与 EVI1 表达增加和预后不良相关。
Genes Chromosomes Cancer. 2012 Dec;51(12):1079-85. doi: 10.1002/gcc.21992. Epub 2012 Aug 8.
7
Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.急性髓系白血病中 WHO 类型 inv(3)(q21q26.2)/t(3;3)(q21;q26.2) 和其他各种 3q 异常的临床、分子和预后意义。
J Clin Oncol. 2010 Aug 20;28(24):3890-8. doi: 10.1200/JCO.2010.29.2771. Epub 2010 Jul 26.
8
t(3;8)(q26.2;q24) Often Leads to MECOM/MYC Rearrangement and Is Commonly Associated with Therapy-Related Myeloid Neoplasms and/or Disease Progression.t(3;8)(q26.2;q24) 常导致MECOM/MYC重排,且通常与治疗相关的髓系肿瘤和/或疾病进展相关。
J Mol Diagn. 2019 Mar;21(2):343-351. doi: 10.1016/j.jmoldx.2018.10.005. Epub 2018 Dec 19.
9
Data on rearrangement-driven chromosomal aberrations in myeloid malignancies.髓系恶性肿瘤中重排驱动的染色体畸变数据。
Data Brief. 2019 May 23;24:104025. doi: 10.1016/j.dib.2019.104025. eCollection 2019 Jun.
10
EVI1 and GATA2 misexpression induced by inv(3)(q21q26) contribute to megakaryocyte-lineage skewing and leukemogenesis.由inv(3)(q21q26)诱导的EVI1和GATA2异常表达导致巨核细胞系偏向和白血病发生。
Blood Adv. 2020 Apr 28;4(8):1722-1736. doi: 10.1182/bloodadvances.2019000978.

引用本文的文献

1
Case Report: Decitabine and venetoclax sequentially followed by FLAG-Ida and venetoclax with immediate allogeneic stem cell transplantation in newly diagnosed acute myeloid leukemia with chromosome 3 inversion/ rearrangement.病例报告:在新诊断的伴有3号染色体倒位/重排的急性髓系白血病中,先序贯使用地西他滨和维奈克拉,随后使用FLAG-Ida和维奈克拉,并立即进行异基因造血干细胞移植。
Front Oncol. 2025 Mar 27;15:1530852. doi: 10.3389/fonc.2025.1530852. eCollection 2025.
2
Significance of Somatic Mutation Profiling in CML Beyond BCR-ABL: A Retrospective Study of the Indian Population.慢性粒细胞白血病中除BCR-ABL之外的体细胞突变谱分析的意义:一项针对印度人群的回顾性研究
Indian J Hematol Blood Transfus. 2025 Jan;41(1):10-22. doi: 10.1007/s12288-024-01808-9. Epub 2024 Jun 21.
3

本文引用的文献

1
High-resolution structural variant profiling of myelodysplastic syndromes by optical genome mapping uncovers cryptic aberrations of prognostic and therapeutic significance.光学基因组图谱分析骨髓增生异常综合征的高分辨率结构变异谱,揭示了具有预后和治疗意义的隐匿性异常。
Leukemia. 2022 Sep;36(9):2306-2316. doi: 10.1038/s41375-022-01652-8. Epub 2022 Aug 1.
2
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms.世界卫生组织血液淋巴肿瘤分类第五版:髓系和组织细胞/树突状肿瘤。
Leukemia. 2022 Jul;36(7):1703-1719. doi: 10.1038/s41375-022-01613-1. Epub 2022 Jun 22.
3
The ETV6-MECOM fusion protein promotes EMT-related properties by repressing the transactivation activity of E-cadherin promoter in K562 leukemia cells.ETV6-MECOM融合蛋白通过抑制K562白血病细胞中E-钙黏蛋白启动子的反式激活活性来促进上皮-间质转化相关特性。
Biochem Biophys Rep. 2024 Feb 19;38:101667. doi: 10.1016/j.bbrep.2024.101667. eCollection 2024 Jul.
4
Acute myeloid leukemia with unreported translocation (x; 3) (q24; p13): A case report.伴未报道的(X;3)(q24;p13)易位的急性髓系白血病:一例报告
Clin Case Rep. 2024 Feb 20;12(2):e8543. doi: 10.1002/ccr3.8543. eCollection 2024 Feb.
TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemia.
TP53 拷贝数和蛋白表达可提示急性髓系白血病各危险分层的突变状态。
Blood. 2022 Jul 7;140(1):58-72. doi: 10.1182/blood.2021013983.
4
In vivo anti-tumor effect of PARP inhibition in IDH1/2 mutant MDS/AML resistant to targeted inhibitors of mutant IDH1/2.IDH1/2 突变型 MDS/AML 对突变型 IDH1/2 靶向抑制剂耐药患者中 PARP 抑制的体内抗肿瘤作用。
Leukemia. 2022 May;36(5):1313-1323. doi: 10.1038/s41375-022-01536-x. Epub 2022 Mar 10.
5
Newly designed breakapart FISH probe helps to identify cases with true MECOM rearrangement in myeloid malignancies.新型分离式 FISH 探针有助于鉴定髓系恶性肿瘤中存在真正 MECOM 重排的病例。
Cancer Genet. 2022 Apr;262-263:23-29. doi: 10.1016/j.cancergen.2021.12.009. Epub 2021 Dec 23.
6
Comparison of myeloid neoplasms with nonclassic 3q26.2/MECOM versus classic inv(3)/t(3;3) rearrangements reveals diverse clinicopathologic features, genetic profiles, and molecular mechanisms of MECOM activation.具有非经典3q26.2/MECOM与经典inv(3)/t(3;3)重排的髓系肿瘤的比较揭示了MECOM激活的不同临床病理特征、基因谱和分子机制。
Genes Chromosomes Cancer. 2022 Feb;61(2):71-80. doi: 10.1002/gcc.23004. Epub 2021 Oct 28.
7
The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops.白血病癌基因 EVI1 通过 CTCF 介导的环劫持 MYC 超级增强子。
Nat Commun. 2021 Sep 28;12(1):5679. doi: 10.1038/s41467-021-25862-3.
8
NKL Homeobox Gene VENTX Is Part of a Regulatory Network in Human Conventional Dendritic Cells.NKL 同源盒基因 VENTX 是人类常规树突状细胞调控网络的一部分。
Int J Mol Sci. 2021 May 31;22(11):5902. doi: 10.3390/ijms22115902.
9
Identification of therapeutic targets of the hijacked super-enhancer complex in EVI1-rearranged leukemia.鉴定 EVI1 重排白血病中被劫持的超级增强子复合物的治疗靶点。
Leukemia. 2021 Nov;35(11):3127-3138. doi: 10.1038/s41375-021-01235-z. Epub 2021 Apr 28.
10
The acquisition of molecular drivers in pediatric therapy-related myeloid neoplasms.儿科治疗相关髓系肿瘤中分子驱动因素的获得。
Nat Commun. 2021 Feb 12;12(1):985. doi: 10.1038/s41467-021-21255-8.